A G-CSF functionalized scaffold for stem cells seeding: a differentiating device for cardiac purposes

被引:23
|
作者
Spadaccio, Cristiano [1 ]
Rainer, Alberto [2 ]
Trombetta, Marcella [2 ]
Centola, Matteo [2 ]
Lusini, Mario [1 ]
Chello, Massimo [1 ]
Covino, Elvio [1 ]
De Marco, Federico [3 ]
Coccia, Raffaella [4 ]
Toyoda, Yoshiya [5 ]
Genovese, Jorge A. [5 ]
机构
[1] Univ Campus Biomed, CIR, Area Cardiovasc Surg, Rome, Italy
[2] Univ Campus Biomed, CIR, Tissue Engn Lab, Rome, Italy
[3] Regina Elena Inst Canc Res, Virol Lab, I-00161 Rome, Italy
[4] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy
[5] Univ Pittsburgh, Med Ctr, Heart Lung & Esophageal Surg Inst, Cardiac & Mol Biol Lab, Pittsburgh, PA USA
关键词
tissue engineering; 3D scaffold; cardiac graft; electrospinning; PLLA; G-CSF release; connexin; 43; stem cells; differentiation; COLONY-STIMULATING FACTOR; SKELETAL MYOBLAST TRANSPLANTATION; REGENERATE INFARCTED MYOCARDIUM; PASSIVE MECHANICAL-PROPERTIES; LEFT-VENTRICULAR FUNCTION; IN-VITRO TECHNIQUE; GROWTH-FACTOR; CONTROLLED-RELEASE; PARACRINE ACTION; ISCHEMIC-HEART;
D O I
10.1111/j.1582-4934.2010.01100.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Myocardial infarction and its consequences represent one of the most demanding challenges in cell therapy and regenerative medicine. Transfer of skeletal myoblasts into decompensated hearts has been performed through intramyocardial injection. However, the achievements of both cardiomyocyte differentiation and precise integration of the injected cells into the myocardial wall, in order to augment synchronized contractility and avoid potentially life-threatening alterations in the electrical conduction of the heart, still remain a major target to be pursued. Recently, granulocytes colony-stimulating factor (G-CSF) fuelled the interest of researchers for its direct effect on cardiomyocytes, inhibiting both apoptosis and remodelling in the failing heart and protecting from ventricular arrhythmias through the up-regulation of connexin 43 (Cx43). We propose a tissue engineering approach concerning the fabrication of an electrospun cardiac graft functionalized with G-CSF, in order to provide the correct signalling sequence to orientate myoblast differentiation and exert important systemic and local effects, positively modulating the infarction microenvironment. Poly-(l-lactide) electrospun scaffolds were seeded with C2C12 murine skeletal myoblast for 48 hrs. Biological assays demonstrated the induction of Cx43 expression along with morphostructural changes resulting in cell elongation and appearance of cellular junctions resembling the usual cardiomyocyte arrangement at the ultrastructural level. The possibility of fabricating extracellular matrix-mimicking scaffolds able to promote myoblast pre-commitment towards myocardiocyte lineage and mitigate the hazardous environment of the damaged myocardium represents an interesting strategy in cardiac tissue engineering.
引用
收藏
页码:1096 / 1108
页数:13
相关论文
共 50 条
  • [1] Heparin-releasing scaffold for stem cells: a differentiating device for vascular aims
    Spadaccio, Cristiano
    Rainer, Alberto
    Centola, Matteo
    Trombetta, Marcella
    Chello, Massimo
    Lusini, Mario
    Covino, Elvio
    Toyoda, Yoshiya
    Genovese, Jorge A.
    REGENERATIVE MEDICINE, 2010, 5 (04) : 645 - 657
  • [2] A G-CSF Functionalized PLLA Scaffold for Wound Repair: an In Vitro Preliminary Study
    Spadaccio, Cristiano
    Rainer, Alberto
    De Porcellinis, Stefano
    Centola, Matteo
    De Marco, Federico
    Chello, Massimo
    Trombetta, Marcella
    Genovese, Jorge A.
    2010 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2010, : 843 - 846
  • [3] G-CSF enhances the therapeutic potency of stem cells transplantation in spinal cord-injured rats
    Pang, Cheng-Yoong
    Yang, Kuo-Liang
    Fu, Chin-Hua
    Sun, Li-Yi
    Chen, Shin-Yuan
    Liao, Chia-Hsin
    REGENERATIVE MEDICINE, 2019, 14 (06) : 571 - 583
  • [4] Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
    DiPersio, John F.
    Stadtmauer, Edward A.
    Nademanee, Auayporn
    Micallef, Ivana N. M.
    Stiff, Patrick J.
    Kaufman, Jonathan L.
    Maziarz, Richard T.
    Hosing, Chitra
    Frueehauf, Stefan
    Horwitz, Mitchell
    Cooper, Dennis
    Bridger, Gary
    Calandra, Gary
    BLOOD, 2009, 113 (23) : 5720 - 5726
  • [5] Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children
    Vazquez Meraz, Jose Eugenio
    Arellano-Galindo, Jose
    Martinez Avalos, Armando
    Mendoza-Garcia, Emma
    Jimenez-Hernandez, Elva
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [6] Use of concurrent G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease
    L Madero
    M González-Vicent
    J Molina
    R Madero
    V Quintero
    MA Díaz
    Bone Marrow Transplantation, 2000, 26 : 365 - 369
  • [7] The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF
    Moretta, Francesca
    Petronelli, Francesca
    Lucarelli, Barbarella
    Pitisci, Angela
    Bertaina, Alice
    Locatelli, Franco
    Mingari, Maria Cristina
    Moretta, Lorenzo
    Montaldo, Elisa
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 (05) : 1271 - 1278
  • [8] The Effects of G-CSF on Proliferation of Mouse Myocardial Microvascular Endothelial Cells
    Li, Jiming
    Zou, Yunzeng
    Ge, Junbo
    Zhang, Daifu
    Guan, Aili
    Wu, Jian
    Li, Lei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (02): : 1306 - 1315
  • [9] Ischemic Cardiac Complications Following G-CSF
    Eckman, Peter M.
    Bertog, Stefan C.
    Wilson, Robert F.
    Henry, Timothy D.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 76 (01) : 98 - 101
  • [10] Use of concurrent G-CSF plus GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease
    Madero, L
    González-Vicent, M
    Molina, J
    Madero, R
    Quintero, V
    Díaz, MA
    BONE MARROW TRANSPLANTATION, 2000, 26 (04) : 365 - 369